HIV tropism and decreased risk of breast cancer.

Autor: Nancy A Hessol, Laura A Napolitano, Dawn Smith, Yolanda Lie, Alexandra Levine, Mary Young, Mardge Cohen, Howard Minkoff, Kathryn Anastos, Gypsyamber D'Souza, Ruth M Greenblatt, James J Goedert

Publikováno v: PLoS ONE, Vol 5, Iss 12, p e14349 (2010)

During the first two decades of the U.S. AIDS epidemic, and unlike some malignancies, breast cancer risk was significantly lower for women with human immunodeficiency virus (HIV) infection compared to the general population. This deficit in HIV-assoc

Externí odkaz: https://doaj.org/article/096094bcb649418f9db27a92d8927985

A Decade of HIV-1 Drug Resistance in the United States: Trends and Characteristics in a Large Protease/Reverse Transcriptase and Co-Receptor Tropism Database from 2003 to 2012

Autor: Charles M Walworth, Jeannette M. Whitcomb, Mojgan Haddad, Christos J. Petropoulos, Joseph M. Volpe, Owen Solberg, Laura A Napolitano, A. Paquet

Publikováno v: Antiviral Therapy. 19:435-441

Background Drug resistance testing and co-receptor tropism determination are key components of the management of antiretroviral therapy for HIV-1-infected individuals. The purpose of this study was to examine trends of HIV-1 resistance and viral evol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c38c63399f7cf1f602bbd29ce51b73
https://doi.org/10.3851/imp2748

Performance of the Abbott RealTi m e HIV-1 Viral Load Assay Is Not Impacted by Integrase Inhibitor Resistance-Associated Mutations

Autor: Signe Fransen, Gavin Cloherty, Christine Herman, John Hackett, Laura A Napolitano, Thomas P. Young, Neil Parkin, Priscilla Swanson

Publikováno v: Journal of Clinical Microbiology. 49:1631-1634

The Abbott RealTi m e HIV-1 viral load assay uses primers and probes targeted to integrase, which is also the target of integrase inhibitors such as raltegravir. Viral loads of 42 raltegravir-susceptible and 40 raltegravir-resistant specimens were de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8747972364cd1fc31d16d6a75fc2317
https://doi.org/10.1128/jcm.02253-10

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

Autor: Megan Telfer, Joseph Timpone, Tondria Green, Edward P. Acosta, Jay Dwyer, Michael P. DubCrossed Dsign, Ellen S. Chan, Paul E. Sax, David Rusin, Teri Flynn, Raphael J. Landovitz, Todd T. Brown, Carl J. Fichtenbaum, Amy Sbrolla, Jolene Noel-Connor, Cara Wilson, Roula Qaqish, Daniel Reirden, Pamela Poethke, Athe M. N. Tsibris, Olga I. Mendez, Babafemi Taiwo, Jorge Santana, Shelia B. Dunaway, Ge-Youl Kim, Yolanda Smith, Tim Lane, Joseph J. Eron, James F. Rooney, Mark Hite, Vanessa Cajahuaringa, Ilene Wiggins, Cheryl Keenan, Cornelius N Van Dam, Nina Lambert, Beverly E. Sha, Mark Rodrieguez, Orlando Roman, I. Martinez, Miriam Chicurel-Bayard, Cathi Basler, Karen Coleman, Laura A. Napolitano, Robert C. Kalayjian, Bryan Baugh, Fred Nicotera, Baiba Berzins, Roberto C. Arduino, Kathy Melbourne, Tamara James, Mary Adams, Charles Walworth, Kevin Robertson, Alan L. Landay, Princy Kumar, Melody Palmore, Andrea Weiss, Heera R. Jayvant, Christine Griesmer, Igho Ofotokun, Christos J. Petropoulos, Aleshia Thomas, John A. Davis, Pablo Tebas, Amy Gonzales, Patricia Walton, Constance A. Benson, Alex Reinhart, Brenda Jackson, Rose Kim, Bartolo Santos, Ighovwerha Ofotokun, Annie Luetkemeyer, Heather J. Ribaudo, Karin L. Klingman, Jenifer Baer, Amy Dill, Felicia Williams, Michael T. Yin, Christine Hurley, Hector Bolivar, Edward Seefried, Aadia Rana, Sheryl Storey, Margaret A. Fischl, Hannah Bernath, Aristoteles E. Villamil

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 61(7)

Background. There is a need to prevent or minimize bone loss associated with antiretroviral treatment (ART) initiation. We compared maraviroc (MVC)- to tenofovir disoproxil fumarate (TDF)–containing ART. Methods. This was a double-blind, placebo-co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7ceeb95b46eaab57187a76006535d11
https://pubmed.ncbi.nlm.nih.gov/26060295

Growth Hormone–Induced Stimulation of Multilineage Human Hematopoiesis

Autor: Mary Beth Hanley, Laura A. Napolitano, Joseph M. McCune

Publikováno v: STEM CELLS. 23:1170-1179

Growth hormone (GH) has been shown to have significant positive effects on hemato-lymphopoiesis in rodent models and, more recently, to increase thymic mass and circulating naïve CD4+ T cells in humans infected with the human immunodeficiency virus,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb01e4a2d1ca5929b69acf3e9608a101
https://doi.org/10.1634/stemcells.2004-0322